Gilead Sciences said on Monday its experimental HIV treatment was found to be statistically non-inferior to its top-selling ...
Gilead Sciences said on Monday its experimental HIV treatment met the main goal and was found to be statistically ...
Stacker on MSN
Achieving lasting remission for HIV
Knowable Magazine reports on breakthroughs in HIV treatment; engineered antibodies show promise for long-term control, ...
Advancements in HIV/AIDS research, drug development and clinical practice since the 1980s have made it possible for people ...
News Medical on MSN
Researchers See Dramatic Drop in HIV-Infected Immune Cells in Patient After Cancer Treatment Received
Paper in @jclinicalinvest (bit.ly/497z6jo) by @HopkinsMedicine @JHUMed_ID finds patient living w/ #HIV has dramatic drop in ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced positive topline results from the Phase 3 ARTISTRY-2 trial. The ...
Sheen appeared on the “Today” show in 2015 and revealed his HIV status, saying doctors had detected the virus four years ...
The Ghana AIDS Commission (GAC) has expressed concern that poor condom usage among young people, particularly adolescent ...
Nurse practitioners discuss evidence-based cancer screening and risk-reduction strategies that primary care clinicians can implement for patients with HIV.
The Star Worldwide (English) on MSN
HIV gets lion’s share of Kenya-US health deal
In the agreement, the US will help countries build their own health systems over the next five years and stop being overly ...
The tools to stop the spread of HIV are readily available, but experts said they're not getting to the right people.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback